Search results
FDA Tells Vaccine Makers to Target New COVID Variant for Fall
WFMZ Eastern Pennsylvania and Western New Jersey· 7 days agoCOVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot...
Feds try to delay release of non-public COVID vaccine safety data until at least 2026
Just the News· 1 day agoThe Biden administration is seeking to delay until at least 2026 the release of COVID-19 vaccine...
Results are looking promising for a combined COVID and flu vaccine—here's how it could benefit...
Medical Xpress· 6 days agoCombination vaccines have been successfully used for several decades in Australia and around the...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 6 days agoThe U.S. Food and Drug Administration (FDA) has recommended thatCOVID vaccine manufacturers update...
Feeling Sick After Your COVID Vaccine? According to Scientists, It’s Actually a Good Sign
SciTechDaily· 2 days agoA UCSF study suggests that side effects like headaches and chills from COVID-19 vaccines indicate a...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News· 6 days agoThe U.S. Food and Drug Administration (FDA) has recommended thatCOVID vaccine manufacturers update...
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
LA Times via Yahoo News· 2 days agoBlaming the COVID vaccines for a tide of undocumented injuries and deaths is a popular theme in the...
Pfizer stock price analysis: how PFE became a fallen angel | Invezz
Invezz· 3 days agoPfizer (NYSE: PFE) stock price has crashed hard in the past few years as demand for Covid-19 ...
Analysts Set Pfizer Inc. (NYSE:PFE) Price Target at $35.86
ETF DAILY NEWS· 1 day agoPfizer Inc. (NYSE:PFE – Get Free Report) has been assigned an average rating of “Hold” from the fifteen ratings firms that are currently covering the stock, MarketBeat Ratings ...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks· 4 days agoNovavax’s filing is based on guidance from the FDA issued last week, which advised COVID-19 vaccine manufacturers Moderna (MRNA Quick QuoteMRNA - Free Report ...